MarketsStocksGLENMARK
GL

Glenmark Pharmaceuticals Ltd

NSE: GLENMARKBSE: 532296Healthcare
Download Research Report7-page PDF
2,160.20
-0.28%
NSE · auto-updates while market open
Prev Close
₹1,590.20
Day High
₹2,207.40
Day Low
₹2,132.20
Mkt Cap
₹62,042 Cr
P / E
45.5
P / B
5.9
ROE
14.1%
52W High
₹2,474.00
52W Low
₹1,512.80
Key Metrics
Market Cap
₹62,042 Cr
P / E
45.55
P / B
5.91
EV / EBITDA
26.00
ROCE
20.4%
ROE
14.1%
Debt / Equity
0.00
Book Value
₹372.51
EPS
₹48.26
Div Yield
0.2%
Face Value
₹1
Promoter Holding
46.6%
Revenue · ₹ Cr
11k
FY20
11k
FY21
12k
FY22
13k
FY23
12k
FY24
13k
FY25
17k
FY26
Net Profit · ₹ Cr
776
970
994
377
1.0k
1.4k
-1.4k
FY20FY21FY22FY23FY24FY25FY26
EPS · ₹ per share
₹27.5
₹34.4
₹33.4
₹10.5
₹37.1
₹48.3
₹-53.2
FY20FY21FY22FY23FY24FY25FY26
P / E Ratio · price ÷ TTM EPS
236701046210-61Jun 21Feb 23Oct 24Jun 26
P/E 45.1×Median 18.4×TTM EPS
Q1 2026 snapshot
Sales
₹3.96K Cr
Operating profit
-
OPM
-
Net profit
₹301 Cr
EPS
₹10.68
Scorecard · 7 axes
Quality
Good
73/100
Valuation
Weak
45.5×
Growth
Avg
+8.6%
Profitability
Good
17.2%
Performance
Good
+36.7%
Entry Point
Avg
87%
Red Flags
Strong
0 flags
Shareholding Pattern
46.6%Promoter
Promoter46.6%
FII20.3%
DII19.3%
Public13.7%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue3,387.5523,267.893,290.886,247.53,945.083,959.67
Net Profit348.0314.38446.973610.432403.228301.319
NPM %10.3%0.1%1.4%9.8%10.2%7.6%
AlertPre-trade